Literature DB >> 25354465

Risk of ischemic stroke in patients with polymyositis and dermatomyositis: a systematic review and meta-analysis.

Patompong Ungprasert1, Wisit Cheungpasitporn, Karn Wijarnpreecha, Wasin Ahuja, Praveen Ratanasrimetha, Charat Thongprayoon.   

Abstract

Several chronic inflammatory disorders, such as rheumatoid arthritis and systemic lupus erythematosus, have been demonstrated to increase ischemic stroke risk, but the data on polymyositis (PM) and dermatomyositis (DM) remain unclear. We conducted a systematic review and meta-analysis of observational studies that reported odds ratio, relative risk, hazard ratio or standardized incidence ratio comparing ischemic risk in patients with PM/DM versus non-PM/DM participants. Pooled risk ratio and 95 % confidence intervals were calculated using a random-effect, generic inverse variance method of DerSimonian and Laird. Three cohort studies were identified and included in our data analysis. The pooled risk ratio of ischemic stroke in patients with PM/DM was 1.61 (95 % CI 1.28-2.02). The statistical heterogeneity of this meta-analysis was insignificant with an I (2) of 0 %. Our study demonstrated a statistically significant increased ischemic stroke risk among patients with PM/DM.

Entities:  

Mesh:

Year:  2014        PMID: 25354465     DOI: 10.1007/s00296-014-3166-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  26 in total

Review 1.  Risk of coronary artery disease in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis of observational studies.

Authors:  Patompong Ungprasert; Promporn Suksaranjit; Ittikorn Spanuchart; Napat Leeaphorn; Nitipong Permpalung
Journal:  Semin Arthritis Rheum       Date:  2014-03-06       Impact factor: 5.532

2.  Stroke subtypes among young patients with systemic lupus erythematosus.

Authors:  Eswar Krishnan
Journal:  Am J Med       Date:  2005-12       Impact factor: 4.965

Review 3.  Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis.

Authors:  F Montecucco; F Mach
Journal:  Rheumatology (Oxford)       Date:  2008-10-16       Impact factor: 7.580

4.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

Review 5.  Atherosclerosis in patients with autoimmune disorders.

Authors:  Johan Frostegård
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-06-23       Impact factor: 8.311

Review 6.  Inflammation, innate immunity and blood coagulation.

Authors:  J Xu; F Lupu; C T Esmon
Journal:  Hamostaseologie       Date:  2010-01       Impact factor: 1.778

7.  Corticosteroid agents inhibit proliferation of smooth muscle cells from human atherosclerotic arteries in vitro.

Authors:  R Voisard; U Seitzer; R Baur; P C Dartsch; H Osterhues; M Höher; V Hombach
Journal:  Int J Cardiol       Date:  1994-03-01       Impact factor: 4.164

8.  Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden.

Authors:  Bengt Zöller; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  BMC Neurol       Date:  2012-06-18       Impact factor: 2.474

9.  Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study.

Authors:  Jesper Lindhardsen; Ole Ahlehoff; Gunnar Hilmar Gislason; Ole Rintek Madsen; Jonas Bjerring Olesen; Jesper Hastrup Svendsen; Christian Torp-Pedersen; Peter Riis Hansen
Journal:  BMJ       Date:  2012-03-08

10.  Increased risk of ischemic stroke in young patients with ankylosing spondylitis: a population-based longitudinal follow-up study.

Authors:  Chia-Wei Lin; Ya-Ping Huang; Yueh-Hsia Chiu; Yu-Tsun Ho; Shin-Liang Pan
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

View more
  1 in total

Review 1.  Inflammation, Autoimmunity, Infection, and Stroke: Epidemiology and Lessons From Therapeutic Intervention.

Authors:  Neal S Parikh; Alexander E Merkler; Costantino Iadecola
Journal:  Stroke       Date:  2020-02-12       Impact factor: 7.914

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.